Epiroprim
Alternative Names: RO 118958Latest Information Update: 14 Nov 2006
At a glance
- Originator Roche
- Class Antibacterials; Antiprotozoals; Diaminopyrimidines; Small molecules
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Pneumocystis pneumonia; Toxoplasmosis
Most Recent Events
- 06 Sep 2000 No-Development-Reported for Pneumocystis pneumonia in Switzerland (Unknown route)
- 06 Sep 2000 No-Development-Reported for Toxoplasmosis in Switzerland (Unknown route)
- 24 Jul 1995 Phase-I clinical trials for Pneumocystis pneumonia in Switzerland (Unknown route)